AJ

Andrew Jon Newbery

PharmX Technologies Limited | Executive Director, Interim CFO
Mr Newbery's experience as a CEO, COO, and CFO of listed companies. His strengths in financial management and mergers and acquisitions will provide strategic oversight as it continues to scale its business operations. He is Chair of Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
PHX
PharmX Technologies Limited
  • Executive Director
  • Interim CFO
6yrs, 4mthFeb 2020
COO
Corum Group Limited
  • Non-Executive Director
6yrs, 4mthFeb 2020
XF1
Xref Limited
  • Non-Executive Director
1yrs, 3mthMar 2025

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
XF1
Xref Limited
18/03/260N/A0N/A
PHX
PharmX Technologies Limited
20/08/25824,837888,576N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
XF1
Xref Limited
18/03/26
Cancelled
900,000$0.090$81,000Cancellation of securities
COO
Corum Group Limited
11/12/20
Buy
107,526$0.098$10,548On-market trade
COO
Corum Group Limited
11/12/20
Buy
265,957$0.098$26,090On-market trade
COO
Corum Group Limited
29/09/20
Issued
155,655$0.042$6,537Rights issue
COO
Corum Group Limited
29/09/20
Issued
179,328$0.042$7,531Rights issue